4
Changes in Ownership
Tempest Therapeutics, Inc. Filed Acc 0001179110-17-000824
Options or other derivatives
- Chief Financial Officer acquired 100,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Couturier Christophe Chief Financial Officer | 2017-01-05 | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | D | ||
Loading xslF345X03/edgar.xml…